Sortilin-related Receptor with A-type Repeats (SORLA) Affects the Amyloid Precursor Protein-dependent Stimulation of ERK Signaling and Adult Neurogenesis*

Sortilin-related receptor with A-type repeats (SORLA) is a sorting receptor that impairs processing of amyloid precursor protein (APP) to soluble (s) APP and to the amyloid β-peptide in cultured neurons and is poorly expressed in patients with Alzheimer disease (AD). Here, we evaluated the consequences of Sorla gene defects on brain anatomy and function using mouse models of receptor deficiency. In line with a protective role for SORLA in APP metabolism, lack of the receptor results in increased amyloidogenic processing of endogenous APP and in aggravated plaque deposition when introduced into PDAPP mice expressing mutant human APP. Surprisingly, increased levels of sAPP caused by receptor deficiency correlate with pro-found stimulation of neuronal ERK signaling and with enhanced neurogenesis, providing in vivo support for neurotrophic functions of sAPP. Our data document a role for SORLA not only in control of plaque burden but also in APP-dependent neuronal signaling and suggest a molecular explanation for increased neurogenesis observed in some AD patients.

[1]  Lin Xie,et al.  Increased hippocampal neurogenesis in Alzheimer's disease , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[2]  Paul Scherz,et al.  Functional analysis of secreted and transmembrane proteins critical to mouse development , 2001, Nature Genetics.

[3]  I. Galve-Roperh,et al.  The Endocannabinoid Anandamide Inhibits Neuronal Progenitor Cell Differentiation through Attenuation of the Rap1/B-Raf/ERK Pathway* , 2002, The Journal of Biological Chemistry.

[4]  B. Hyman,et al.  Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[5]  J. Nyengaard,et al.  Sorting by the Cytoplasmic Domain of the Amyloid Precursor Protein Binding Receptor SorLA , 2007, Molecular and Cellular Biology.

[6]  P. Lucassen,et al.  Increased proliferation reflects glial and vascular-associated changes, but not neurogenesis in the presenile Alzheimer hippocampus , 2006, Neurobiology of Disease.

[7]  B. Hyman,et al.  Interaction of the Cytosolic Domains of sorLA/LR11 with the Amyloid Precursor Protein (APP) and β-Secretase β-Site APP-Cleaving Enzyme , 2006, The Journal of Neuroscience.

[8]  K. Lunetta,et al.  The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease , 2007, Nature Genetics.

[9]  George Perry,et al.  Distribution, levels, and activation of MEK1 in Alzheimer's disease , 2003, Journal of neurochemistry.

[10]  J. Egan,et al.  Amyloid precursor protein requires the insulin signaling pathway for neurotrophic activity. , 1997, Brain research. Molecular brain research.

[11]  A. Mccarthy.  Development , 1996, Current Opinion in Neurobiology.

[12]  宁北芳,et al.  疟原虫var基因转换速率变化导致抗原变异[英]／Paul H, Robert P, Christodoulou Z, et al//Proc Natl Acad Sci U S A , 2005 .

[13]  Y. Kwak,et al.  Amyloid precursor protein is involved in staurosporine induced glial differentiation of neural progenitor cells. , 2006, Biochemical and biophysical research communications.

[14]  P. Eriksson,et al.  Opioid-induced proliferation through the MAPK pathway in cultures of adult hippocampal progenitors , 2003, Molecular and Cellular Neuroscience.

[15]  Thomas Rülicke,et al.  Behavioral and anatomical deficits in mice homozygous for a modified β-amyloid precursor protein gene , 1994, Cell.

[16]  Z. Nagy.  The last neuronal division: a unifying hypothesis for the pathogenesis of Alzheimer's disease , 2005, Journal of cellular and molecular medicine.

[17]  T. Bliss,et al.  Arc/Arg3.1 Is Essential for the Consolidation of Synaptic Plasticity and Memories , 2006, Neuron.

[18]  G. Collingridge,et al.  Age-Related Impairment of Synaptic Transmission But Normal Long-Term Potentiation in Transgenic Mice that Overexpress the Human APP695SWE Mutant Form of Amyloid Precursor Protein , 2001, The Journal of Neuroscience.

[19]  T. Bayer,et al.  Alzheimer β-Amyloid Homodimers Facilitate Aβ Fibrillization and the Generation of Conformational Antibodies* , 2003, Journal of Biological Chemistry.

[20]  A. Prochiantz,et al.  Soluble form of amyloid precursor protein regulates proliferation of progenitors in the adult subventricular zone , 2004, Development.

[21]  G. Kirfel,et al.  Cytoprotective function of sAPPα in human keratinocytes , 2004 .

[22]  R. Nicoll,et al.  Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[23]  P. Baeuerle,et al.  Transcription factor NF-κB is activated in primary neurons by amyloid β peptides and in neurons surrounding early plaques from patients with Alzheimer disease , 1997 .

[24]  R. Rosenfeld.  Nature , 2009, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[25]  W. Schneider,et al.  A novel mosaic protein containing LDL receptor elements is highly conserved in humans and chickens. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[26]  P. Hof,et al.  Overexpression of Wild Type But Not an FAD Mutant Presenilin-1 Promotes Neurogenesis in the Hippocampus of Adult Mice , 2002, Neurobiology of Disease.

[27]  Xiongwei Zhu,et al.  Differential activation of neuronal ERK, JNK/SAPK and p38 in Alzheimer disease: the ‘two hit’ hypothesis , 2001, Mechanisms of Ageing and Development.

[28]  M. Mattson,et al.  Phosphatidylinositol-3-Kinase–Akt Kinase and p42/p44 Mitogen-Activated Protein Kinases Mediate Neurotrophic and Excitoprotective Actions of a Secreted Form of Amyloid Precursor Protein , 2002, Experimental Neurology.

[29]  N. Holbrook,et al.  Activation of neuronal extracellular receptor kinase (ERK) in Alzheimer disease links oxidative stress to abnormal phosphorylation. , 1999, Neuroreport.

[30]  D. Selkoe,et al.  Secreted beta-amyloid precursor protein stimulates mitogen-activated protein kinase and enhances tau phosphorylation. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[31]  W. Wallace,et al.  Characterization of the neurotrophic interaction between nerve growth factor and secreted α‐amyloid precursor protein , 2001, Journal of neuroscience research.

[32]  Yaakov Stern,et al.  The association between genetic variants in SORL1 and Alzheimer disease in an urban, multiethnic, community-based cohort. , 2007, Archives of neurology.

[33]  A. Levey,et al.  Loss of apolipoprotein E receptor LR11 in Alzheimer disease. , 2004, Archives of neurology.

[34]  I. Ferrer,et al.  Phosphorylated Map Kinase (ERK1, ERK2) Expression is Associated with Early Tau Deposition in Neurones and Glial Cells, but not with Increased Nuclear DNA Vulnerability and Cell Death, in Alzheimer Disease, Pick's Disease, Progressive Supranuclear Palsy and Corticobasal Degeneration , 2001, Brain pathology.

[35]  M. Shelanski,et al.  Neurogenic Effect of β-Amyloid Peptide in the Development of Neural Stem Cells , 2004, The Journal of Neuroscience.

[36]  A. Levey,et al.  The Lipoprotein Receptor LR11 Regulates Amyloid β Production and Amyloid Precursor Protein Traffic in Endosomal Compartments , 2006, The Journal of Neuroscience.

[37]  N. Tommerup,et al.  Molecular Characterization of a Novel Human Hybrid-type Receptor That Binds the α2-Macroglobulin Receptor-associated Protein* , 1996, The Journal of Biological Chemistry.

[38]  A. Sporbert,et al.  SorLA/LR11 Regulates Processing of Amyloid Precursor Protein via Interaction with Adaptors GGA and PACS-1* , 2007, Journal of Biological Chemistry.

[39]  L. Mucke,et al.  Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein , 1995, Nature.

[40]  D. Wilkin,et al.  Neuron , 2001, Brain Research.

[41]  T. Montine,et al.  LR11/SorLA Expression Is Reduced in Sporadic Alzheimer Disease but not in Familial Alzheimer Disease , 2006, Journal of neuropathology and experimental neurology.